showed a trendp = .05
With regards to FEV1, the combined cell-dose groups showed a trend of improvement at 3 months (0.12 L [95% CI: 0.0007, 0.24], p = .05) and 6 months (0.09 L [95% CI: −0.06, 0.24], p = .23).
With regards to FEV1, the combined cell-dose groups showed a trend of improvement at 3 months (0.12 L [95% CI: 0.0007, 0.24], p = .05) and 6 months (0.09 L [95% CI: −0.06, 0.24], p = .23).